<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1480">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04468412</url>
  </required_header>
  <id_info>
    <org_study_id>NL2020-6555</org_study_id>
    <nct_id>NCT04468412</nct_id>
  </id_info>
  <brief_title>Influence of COVID-19 on Vascular Endothelial Function</brief_title>
  <acronym>COVAS</acronym>
  <official_title>Influence of COVID-19 on Vascular Endothelial Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bernhoven Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Radboud University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rationale: Infection with severe acute respiratory syndrome coronavirus (SARS-CoV) 2 could
      result in endothelial dysfunction with increased risk of arterial thrombotic events by
      downregulating the expression of angiotensin converting enzyme 2 (ACE2). Endothelial function
      can be easily and non-invasively determined by carotid artery reactivity (CAR) testing.

      Objective: To investigate the predictive value of endothelial dysfunction, measured by
      carotid artery reactivity testing, for 1-year cardiovascular events in patients with past
      COVID-19 infection.

      Study design: A prospective observational longitudinal cohort study.

      Study population: Patients recovered from confirmed infection with SARS-CoV2.

      Main study parameters/endpoints: macrovascular endothelial function measured by carotid
      artery reactivity testing.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 14, 2020</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Endothelial dysfunction</measure>
    <time_frame>CAR will be measures between 6 and 20 weeks and 1 year after recovery from COVID-19.</time_frame>
    <description>Change in endothelial dysfunction as determined by CAR test.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiovascular events (MACE)</measure>
    <time_frame>1 year</time_frame>
    <description>MACE include non-fatal myocardial infarction, non-fatal ischemic stroke, acute limb ischemia, need for revascularization, amputation and cardiovascular death.</description>
  </secondary_outcome>
  <enrollment type="Actual">203</enrollment>
  <condition>COVID</condition>
  <condition>Vascular; Damage</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Carotid Artery Reactivity Testing</intervention_name>
    <description>The carotid artery reactivity (CAR) test assesses macrovascular endothelial function by measuring the carotid artery diameter in response to sympathetic stimulation. Participants are in the supine position with the neck extended for assessment of the carotid artery. Left carotid artery diameter is recorded continuously during baseline (30 seconds) and during immersion of the right hand up to the wrist in icy water (4°C) for 3 minutes. CAR can either represent a dilatory response (normal endothelial function) or a constrictive response (endothelial dysfunction) of the carotid artery.</description>
    <other_name>Cold pressor test</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with past COVID-19 infection will be recruited at Bernhoven hospital, the
        Netherlands.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Confirmed SARS-CoV2 infection by polymerase chain reaction on nasopharyngeal swab,
             sputum or bronchoalveolar lavage.

          -  At least 6 and no more than 20 weeks after resolution of COVID-19 related symptoms

          -  ≥ 16 years old

        Exclusion Criteria:

          -  Recent (&lt;3 months) angina pectoris, myocardial infarction, stroke, or heart failure

          -  Raynaud syndrome, scleroderma, complex regional pain syndrome of the upper extremity
             or presence of arteriovenous fistula or open wounds on both the upper extremities.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michiel C Warle, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Radboud University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andre S van Petersen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Benhoven</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bernhoven</name>
      <address>
        <city>Uden</city>
        <zip>5406 PT</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 9, 2020</study_first_submitted>
  <study_first_submitted_qc>July 10, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 13, 2020</study_first_posted>
  <last_update_submitted>September 14, 2020</last_update_submitted>
  <last_update_submitted_qc>September 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 16, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

